Your Location:
Home >
Browse articles >
Clinical Observation of Modified Huanglian Wendantang in Treatment of Cardiovascular Risk Factors in Patients with Metabolic Syndrome Under Guidance of Treating Disease before Its Onset
Clinical Observation of Modified Huanglian Wendantang in Treatment of Cardiovascular Risk Factors in Patients with Metabolic Syndrome Under Guidance of Treating Disease before Its Onset
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 9, Pages: 142-149(2025)
DOI: 10.13422/j.cnki.syfjx.20250993
Accepted:07 January 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 0 ) Tabs( 6 )
References
Publication Info
Metrics
469
Views
725
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Effects of Modified Huanglian Wendantang on Chronic Inflammation and Vascular Endothelial Function in Metabolic Syndrome
Effect of Huanglian Wendantang in Treatment of Metabolic Syndrome
Pathogenesis, Pattern and Treatment of Atrial Fibrillation Comorbid with Metabolic Syndrome Based on Theory of "Deficiency, Stagnation, Phlegm, and Blood Stasis"
Effect of Huayu Jiedu Prescription on Oxygen-glucose Deprivation-induced Injury in Brain Microvascular Endothelial Cells Based on PI3K/Akt/mTOR Autophagy Related Pathway
Tangbikang Granules Improve Diabetic Peripheral Neuropathy by Inhibiting Ferroptosis via AMPK/Nrf2 Signaling Pathway
Related Author
HAN Yubo
ZOU Guoliang
WANG Ruinan
YAO Chunli
LIU Li
DONG Xinyu
ZOU Guoliang
HAN Yubo
Related Institution
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
First Affiliated Hospital,Heilongjiang University of Chinese Medicine
Beijing University of Chinese Medicine
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Affiliated Hospital of Shaanxi University of Chinese Medicine


